• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肥胖成年人袖状胃切除术后 2 型糖尿病缓解相关的因素。

Factors associated with resolution of type-2 diabetes mellitus after sleeve gastrectomy in obese adults.

机构信息

Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

General Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

出版信息

Sci Rep. 2021 Mar 16;11(1):6002. doi: 10.1038/s41598-021-85450-9.

DOI:10.1038/s41598-021-85450-9
PMID:33727637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7966796/
Abstract

Many bariatric procedures are more effective for improving type-2 diabetes mellitus (T2DM) than conventional pharmacotherapy. The current research evaluated factors linked to complete and partial remission or improvement of T2DM after laparoscopic sleeve gastrectomy (LSG). The current prospective study included all diabetic patients who were submitted LSG between January 2015 and June 2018 and completed a 2-year follow-up period. Patients were assessed at baseline and 2 years after LSG. This work comprised of 226 diabetic cases. Two years after LSG, 86 patients (38.1%) achieved complete remission of DM, and 24 (10.6%) reached partial remission. Only 14 patients (6.2%) showed no change in their diabetic status. On univariate analysis, age ≤ 45 years, duration of diabetes ≤ 5 years, use of a single oral antidiabetic, HbA1c ≤ 6.5%, HOMA-IR ≤ 4.6, C-peptide > 2.72 ng/mL, and BMI ≤ 40 kg/m predicted complete remission. The independent predictors of complete remission were age ≤ 45 years, duration of diabetes ≤ 5 years, use of a single oral antidiabetic, HOMA-IR ≤ 4.6, and C-peptide > 2.72 ng/mL. A combined marker of young age, short duration of DM, and low HOMA-IR predicted complete remission with sensitivity 93% and specificity 82%. Independent predictors of complete remission of T2DM after LSG were younger age, shorter duration, single oral antidiabetic, lower HOMA-IR, and higher C-peptide.

摘要

许多减重手术在改善 2 型糖尿病(T2DM)方面比传统药物治疗更有效。本研究评估了腹腔镜袖状胃切除术(LSG)后与 T2DM 完全和部分缓解或改善相关的因素。本前瞻性研究纳入了 2015 年 1 月至 2018 年 6 月间接受 LSG 的所有糖尿病患者,并完成了 2 年的随访。患者在 LSG 前和 2 年后进行评估。本研究共纳入 226 例糖尿病患者。LSG 后 2 年,86 例(38.1%)患者达到 DM 完全缓解,24 例(10.6%)患者达到部分缓解。仅有 14 例(6.2%)患者糖尿病状态无变化。单因素分析显示,年龄≤45 岁、糖尿病病程≤5 年、使用一种口服降糖药、HbA1c≤6.5%、HOMA-IR≤4.6、C 肽>2.72ng/ml 和 BMI≤40kg/m2 预测完全缓解。年龄≤45 岁、糖尿病病程≤5 年、使用一种口服降糖药、HOMA-IR≤4.6 和 C 肽>2.72ng/ml 是完全缓解的独立预测因素。年龄小、糖尿病病程短、HOMA-IR 低的联合标志物预测完全缓解的敏感性为 93%,特异性为 82%。LSG 后 T2DM 完全缓解的独立预测因素是年龄较小、糖尿病病程较短、单一口服降糖药、较低的 HOMA-IR 和较高的 C 肽。

相似文献

1
Factors associated with resolution of type-2 diabetes mellitus after sleeve gastrectomy in obese adults.与肥胖成年人袖状胃切除术后 2 型糖尿病缓解相关的因素。
Sci Rep. 2021 Mar 16;11(1):6002. doi: 10.1038/s41598-021-85450-9.
2
Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy.袖状胃切除术后肥胖成年人 1 年后糖尿病完全缓解、部分缓解、改善或状态不变的相关因素。
Surg Obes Relat Dis. 2020 Oct;16(10):1521-1530. doi: 10.1016/j.soard.2020.05.013. Epub 2020 May 27.
3
Effect of Laparoscopic Sleeve Gastrectomy on Type 2 Diabetes Mellitus in Patients with Body Mass Index less than 30 kg/m.腹腔镜袖状胃切除术对 BMI 小于 30kg/m²的 2 型糖尿病患者的影响。
Obes Surg. 2019 Mar;29(3):835-842. doi: 10.1007/s11695-018-3602-4.
4
Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.日本袖状胃切除术联合十二指肠-空肠旁路术治疗肥胖重症糖尿病患者的疗效:一项回顾性多中心研究
Obes Surg. 2018 Feb;28(2):497-505. doi: 10.1007/s11695-017-2874-4.
5
Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score.腹腔镜袖状胃切除术治疗2型糖尿病:用ABCD评分预测手术成功率
Surg Obes Relat Dis. 2015 Sep-Oct;11(5):991-6. doi: 10.1016/j.soard.2014.12.027. Epub 2014 Dec 31.
6
Preserving β-cell function is the major determinant of diabetes remission following laparoscopic sleeve gastrectomy in Japanese obese diabetic patients.腹腔镜胃袖状切除术治疗日本肥胖糖尿病患者后,β细胞功能的保存是糖尿病缓解的主要决定因素。
Endocr J. 2019 Sep 28;66(9):817-826. doi: 10.1507/endocrj.EJ19-0054. Epub 2019 Jun 1.
7
Laparoscopic Ileal Interposition with Diverted Sleeve Gastrectomy Versus Laparoscopic Transit Bipartition with Sleeve Gastrectomy for Better Glycemic Outcomes in T2DM Patients.腹腔镜回肠插入术联合袖状胃切除术转流与腹腔镜袖状胃切除术转流二分法对2型糖尿病患者改善血糖结局的比较
Obes Surg. 2018 Jan;28(1):77-86. doi: 10.1007/s11695-017-2803-6.
8
Type 2 Diabetes Remission 5 Years After Laparoscopic Sleeve Gastrectomy: Multicenter Cohort Study.腹腔镜袖状胃切除术 5 年后 2 型糖尿病缓解:多中心队列研究。
Obes Surg. 2021 Mar;31(3):980-986. doi: 10.1007/s11695-020-05088-w. Epub 2020 Nov 5.
9
The effect of laparoscopic sleeve gastrectomy on type 2 diabetes remission outcomes in patients with body mass index between 25 kg/m 2 and 32.5 kg/m 2.腹腔镜袖状胃切除术对体重指数在25kg/m²至32.5kg/m²之间的患者2型糖尿病缓解结局的影响。
Asian J Surg. 2022 Jan;45(1):315-319. doi: 10.1016/j.asjsur.2021.06.001. Epub 2021 Jul 8.
10
Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy.2 型糖尿病病史 10 年是袖状胃切除术缓解的预后因素。
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):697-702. doi: 10.1016/j.soard.2011.08.014. Epub 2011 Aug 28.

引用本文的文献

1
Comparison of SADI-S Versus SG in Chinese with Diabetes and BMI < 35 kg/m2:a Retrospective Study with Medium-Term Outcomes.在中国糖尿病患者且体重指数(BMI)< 35kg/m² 的人群中,SADI-S 与 SG 的比较:一项中期结果的回顾性研究
Obes Surg. 2025 May;35(5):1660-1671. doi: 10.1007/s11695-025-07809-5. Epub 2025 Mar 25.
2
The role of gut microbiota in predicting the weight loss following laparoscopic sleeve gastrectomy.肠道微生物群在预测腹腔镜袖状胃切除术后体重减轻中的作用。
Front Microbiol. 2025 Mar 3;16:1560368. doi: 10.3389/fmicb.2025.1560368. eCollection 2025.
3
Surgical Strategies for the Management of Obesity.肥胖管理的手术策略
Methodist Debakey Cardiovasc J. 2025 Feb 18;21(2):84-93. doi: 10.14797/mdcvj.1513. eCollection 2025.
4
Diabetes Remission After Bariatric Surgery: A 10-Year Follow-Up Study.减重手术后的糖尿病缓解:一项10年随访研究
Obes Surg. 2025 Jan;35(1):161-169. doi: 10.1007/s11695-024-07592-9. Epub 2024 Dec 23.
5
Challenges of Revisional Metabolic and Bariatric Surgery: A Comprehensive Guide to Unraveling the Complexities and Solutions of Revisional Bariatric Procedures.修订代谢与减重手术的挑战:解开减重手术修订复杂性及解决方案的综合指南
J Clin Med. 2024 May 25;13(11):3104. doi: 10.3390/jcm13113104.
6
Identification of circulating apolipoprotein M as a new determinant of insulin sensitivity and relationship with adiponectin.鉴定循环载脂蛋白 M 为胰岛素敏感性的新决定因素及其与脂联素的关系。
Int J Obes (Lond). 2024 Jul;48(7):973-980. doi: 10.1038/s41366-024-01510-w. Epub 2024 Mar 15.
7
Cardiometabolic Improvements After Metabolic Surgery and Related Presurgery Factors.代谢手术后的心脏代谢改善及相关术前因素
J Endocr Soc. 2024 Mar 14;8(5):bvae027. doi: 10.1210/jendso/bvae027. eCollection 2024 Mar 12.
8
Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study.与袖状胃切除术相关的研究全球趋势:一项文献计量学与可视化研究
World J Gastrointest Surg. 2021 Nov 27;13(11):1509-1522. doi: 10.4240/wjgs.v13.i11.1509.
9
Bariatric Surgery in Cebu, Philippines: Current Status and Initial Experience With Laparoscopic Sleeve Gastrectomy.菲律宾宿务的减重手术:腹腔镜袖状胃切除术的现状与初步经验
Cureus. 2021 Oct 21;13(10):e18953. doi: 10.7759/cureus.18953. eCollection 2021 Oct.

本文引用的文献

1
Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda-a descriptive retrospective study.乌干达 2 型糖尿病患者超重和肥胖的流行情况及相关因素:一项描述性回顾性研究。
BMJ Open. 2020 Nov 4;10(11):e039258. doi: 10.1136/bmjopen-2020-039258.
2
Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy.袖状胃切除术后肥胖成年人 1 年后糖尿病完全缓解、部分缓解、改善或状态不变的相关因素。
Surg Obes Relat Dis. 2020 Oct;16(10):1521-1530. doi: 10.1016/j.soard.2020.05.013. Epub 2020 May 27.
3
Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.胃旁路术和袖状胃切除术治疗 2 型糖尿病早期改善的比较:出院时停药可预测 1 年的结果。
Surg Obes Relat Dis. 2019 Dec;15(12):2025-2032. doi: 10.1016/j.soard.2019.04.004. Epub 2019 Apr 22.
4
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.人类胰岛素抵抗和 2 型糖尿病中的β细胞命运:胰岛可塑性的视角。
Diabetes. 2019 Jun;68(6):1121-1129. doi: 10.2337/db18-0856.
5
Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery.减重或代谢手术后2型糖尿病缓解的预测
J Obes Metab Syndr. 2018 Dec;27(4):213-222. doi: 10.7570/jomes.2018.27.4.213. Epub 2018 Dec 30.
6
Hepatic Insulin Clearance: Mechanism and Physiology.肝脏胰岛素清除:机制与生理学。
Physiology (Bethesda). 2019 May 1;34(3):198-215. doi: 10.1152/physiol.00048.2018.
7
Which Bariatric Procedure Is the Most Popular in the World? A Bibliometric Comparison.世界上最受欢迎的减肥手术是哪种?文献计量学比较。
Obes Surg. 2018 Aug;28(8):2339-2352. doi: 10.1007/s11695-018-3163-6.
8
Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.糖尿病手术研究中,5年时生活方式干预与药物治疗联合或不联合Roux-en-Y胃旁路手术对糖化血红蛋白、低密度脂蛋白胆固醇和收缩压的控制情况
JAMA. 2018 Jan 16;319(3):266-278. doi: 10.1001/jama.2017.20813.
9
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity.个体化代谢手术评分:基于糖尿病严重程度的手术选择。
Ann Surg. 2017 Oct;266(4):650-657. doi: 10.1097/SLA.0000000000002407.
10
The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.高级-DiaRem 评分提高了 Roux-en-Y 胃旁路术后 1 年糖尿病缓解的预测能力。
Diabetologia. 2017 Oct;60(10):1892-1902. doi: 10.1007/s00125-017-4371-7. Epub 2017 Jul 21.